PULMONX CORPORATION - COMMON STOCK

Pulmonx Reports Second Quarter 2022 Financial Results

02 Aug 2022 16:05:03 By Nasdaq GlobeNewswire

Pulmonx Reports First Quarter 2022 Financial Results

03 May 2022 16:05:01 By Nasdaq GlobeNewswire

Pulmonx to Present at the Bank of America Securities 2022 Healthcare Conference

26 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Report First Quarter 2022 Financial Results on May 3, 2022

19 Apr 2022 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Reports Fourth Quarter and Full Year 2021 Financial Results

23 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

Pulmonx to Present at the Citi 2022 Virtual Healthcare Conference

10 Feb 2022 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Report Fourth Quarter and Full Year 2021 Financial Results on February 23, 2022

09 Feb 2022 16:05:01 By Nasdaq GlobeNewswire

Pulmonx to Present at the 40th Annual J.P. Morgan Healthcare Conference

29 Dec 2021 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Present at the 33rd Annual Piper Sandler Healthcare Conference

16 Nov 2021 16:05:00 By Nasdaq GlobeNewswire

Pulmonx to Participate at Upcoming Investor Conferences

03 Nov 2021 08:00:02 By Nasdaq GlobeNewswire

Pulmonx Reports Third Quarter 2021 Financial Results

02 Nov 2021 16:05:01 By Nasdaq GlobeNewswire

Pulmonx to Report Third Quarter 2021 Financial Results on November 2, 2021

26 Oct 2021 16:05:01 By Nasdaq GlobeNewswire

Pulmonx to Present at Upcoming September Investor Conferences

26 Aug 2021 16:05:00 By Nasdaq GlobeNewswire

Pulmonx Reports Second Quarter 2021 Financial Results

03 Aug 2021 16:05:01 By Nasdaq GlobeNewswire

Pulmonx Welcomes Two New Board Members, Adding Expertise in Health Technology, Consumer Marketing, and Integrated Healthcare Delivery Networks

02 Aug 2021 08:45:00 By Nasdaq GlobeNewswire

Pulmonx to Present at the Canaccord Genuity 41st Annual Growth Conference

29 Jul 2021 16:05:02 By Nasdaq GlobeNewswire

Pulmonx to Report Second Quarter 2021 Financial Results on August 3, 2021

20 Jul 2021 16:05:00 By Nasdaq GlobeNewswire

Zephyr® Valve Treatment Provides Long-Term Quality of Life and Lung Function Improvements for Patients with Severe COPD/Emphysema

17 May 2021 16:05:01 By Nasdaq GlobeNewswire

Pulmonx Reports First Quarter 2021 Financial Results

04 May 2021 16:02:00 By Nasdaq GlobeNewswire

Pulmonx Corporation Expands Leadership Team

04 May 2021 16:01:00 By Nasdaq GlobeNewswire